Our Team: Passionate - Innovative - Disciplined
EV Therapeutics is a pre-clinical stage biotechnology company comprised of passionate scientists, clinical and regulatory experts, and seasoned commercial leaders who are devoted to developing first-in-class immunotherapies based on modified tumor-derived extracellular vesicles (mTEVs) to significantly EVolve advanced cancer therapy and other unmet medical needs that are addressable with our proprietary technology platform.
Subree Subramanian, MS, Ph.D.
CSO, Co-founder
- Professor of Medicine
- Stanford University - Post doc. trained under Nobel Laureate Dr. Andrew Fire
- 120 peer-reviewed publications
- Cancer biology expertise
Scientific & Business Advisors
At EV Therapeutics the Scientific and Business Advisors fulfill a leadership role by providing management with scientific and technical guidance, expertise, and oversight. Their insight is often sought early in the process of evaluating the validity and viability of our therapeutic. They also serve a critical role in establishing strategic and business guidance for our product development, clinical, and regulatory road map.
Paul Robbins, Ph.D.
Dr. Robbins is a Professor of Medicine at the University of Minnesota where he's conducting research on the use of extracellular vesicles for immunoregulatory therapeutics applications.
Xianda Zhao M.D., Ph.D.
Dr. Zhao is medical school graduate from the University of Minnesota and practicing physician. His brings clinical oncology expertise and co-discovered the key intrinsic resistance factor that prevents T cells in our immune system from being activated by checkpoint inhibitors.
-
![]()
Marie DeGayner, RPh, FRAPS, RAC
Button
Marie DeGayner, RPh, FRAPS, RAC
Ms. DeGayner bring over 25 yrs of clinical, regulatory affairs, and compliance and quality experience.
Frances McCloskey, CPA, CFA, MBA
Ms. McCloskey is a CPA and brings > 25 years in financial management experiences. She served as CFO and controller for many medium sized organization and built her experience as a former employee of Coopers & Lybrand, LLP. She is a graduate of the University of Minnesota Carlson School of Mgmt.
-
![]()
Prem Premsrirut, MD, PhD
Button
Prem Premsrirut, MD, PhD
President and CEO, Mirimus
Assistant Research Professor,
Cell Biology, SUNY Downstate
Health Sciences University
